Rasha Aboelhassan, Senior Oncology Consultant at Nasser Institute Hospital, shared a post on LinkedIn:

“I still remember when the CATCH study team approached me to join them. ( about 10 years ago)

It was my first time as a principal investigator.
I was very excited, not only for the opportunity to join this amazing team, but also for the prospect of switching treatment for VTE cancer patients from oral anticoagulants to LMWH.

I won two competitions in the CATCH study:

Top 10 best Sites

Best Recruitment Site”

CATCH: a randomised clinical trial comparing long-term tinzaparin versus warfarin for treatment of acute venous thromboembolism in cancer patients

Authors: Agnes YY Lee et al.

Rasha Aboelhassan

More posts featuring Rasha Aboelhassan on OncoDaily.

Rasha Aboelhassan reflects on her journey with the CATCH study: 10 years in cancer research

“I still remember when the CATCH study team approached me to join them. ( about 10 years ago)

It was my first time as a principal investigator.
I was very excited, not only for the opportunity to join this amazing team, but also for the prospect of switching treatment for VTE cancer patients from oral anticoagulants to LMWH.

I won two competitions in the CATCH study:

Rasha Aboelhassan reflects on her journey with the CATCH study: 10 years in cancer research

“I still remember when the CATCH study team approached me to join them. ( about 10 years ago)

It was my first time as a principal investigator. I was very excited, not only for the opportunity to join this amazing team, but also for the prospect of switching treatment for VTE cancer patients from oral anticoagulants to LMWH.

I won two competitions in the CATCH study:

It was my first time as a principal investigator.
I was very excited, not only for the opportunity to join this amazing team, but also for the prospect of switching treatment for VTE cancer patients from oral anticoagulants to LMWH.